Cases

Search for a case

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Cases

January 2, 2024

Via Renewables, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Via Renewables, Inc. (“Via” or the “Company”) (NASDAQ: VIA), in connection with its acquisition by Retailco, LLC. Under the merger agreement, the Company’s shareholders will receive $11.00 per share.

Join Case →

December 26, 2023

RayzeBio, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of RayzeBio, Inc. (“RayzeBio” or the “Company”) (NASDAQ: RYZB), in connection with its acquisition by Bristol Myers Squibb Company (NYSE: BMY) via tender offer. Under the merger agreement, the Company’s shareholders will receive $62.50 per share. The transaction is valued at approximately $14.1 billion.

Join Case →

December 26, 2023

Karuna Therapeutics, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Karuna Therapeutics, Inc. (“Karuna” or the “Company”) (NASDAQ: KRTX), in connection with its acquisition by Bristol Myers Squibb Company (NYSE: BMY) . Under the merger agreement, the Company’s shareholders will receive $330.00 per share. The transaction is valued at approximately $14.0 billion.

Join Case →

December 26, 2023

Daseke, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Daseke, Inc. (“Daseke” or the “Company”) (NASDAQ: DSKE), in connection with its acquisition by TFI International Inc. (NYSE: TFII). Under the merger agreement, the Company’s shareholders will receive $8.30 per share. The transaction is valued at approximately $1.1 billion.

Join Case →

December 19, 2023

Alteryx, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Alteryx, Inc. (“Alteryx” or the “Company”) (NYSE: AYX), in connection with its acquisition by Clearlake Capital Group, L.P. (together with certain of its affiliates, “Clearlake”) and Insight Partners (“Insight”). Under the merger agreement,the Company’s shareholders will receive $48.25 per share.

Join Case →

December 12, 2023

Icosavax, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Icosavax, Inc. (“Icosavax” or the “Company”) (NASDAQ: ICVX), in connection with its acquisition by a subsidiary of AstraZeneca via tender offer. Under the merger agreement, the Company’s shareholders will receive $15.00 per share, plus a non-tradable contingent value right (“CVR”) for up to $5.00 per share.

Join Case →

November 30, 2023

ImmunoGen, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ImmunoGen, Inc. (“ImmunoGen” or the “Company”) (NASDAQ: IMGN), in connection with its proposed acquisition by AbbVie Inc. (NYSE: ABBV). Under the merger agreement, Company shareholders will receive $31.26 per share.

Join Case →

November 29, 2023

Rover Group, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Rover Group, Inc. (“Rover” or the “Company”) (NASDAQ: ROVR), in connection with its proposed acquisition by private equity funds managed by Blackstone. Under the merger agreement, Company shareholders will receive $11.00 per share.

Join Case →

November 9, 2023

GAN Limited Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of of GAN Limited (“GAN” or the “Company”) (NASDAQ: GAN) in connection with its proposed acquisition by Sega Sammy Creation Inc. Under the merger agreement, the Company’s shareholders will receive $1.97 per share.

Join Case →

We will fight for you and have your back no matter what. Join the tens of thousands of people we’ve helped.

Cases

Search for a case

Cases

Via Renewables, Inc. Investigation

RayzeBio, Inc. Investigation

Karuna Therapeutics, Inc. Investigation

Daseke, Inc. Investigation

Alteryx, Inc. Investigation

Icosavax, Inc. Investigation

ImmunoGen, Inc. Investigation

Rover Group, Inc. Investigation

GAN Limited Investigation

Where to find us?

new york

california

georgia

NEW JERSEY